Edition:
United States

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,486.60GBp
13 Dec 2018
Change (% chg)

7.40 (+0.50%)
Prev Close
1,479.20
Open
1,479.60
Day's High
1,487.20
Day's Low
1,472.60
Volume
904,646
Avg. Vol
8,297,428
52-wk High
1,648.80
52-wk Low
1,235.20

Select another date:

Mon, Dec 3 2018

Photo

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

Deals of the day-Mergers and acquisitions

Dec 3 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

UPDATE 3-GSK slides after buying cancer firm Tesaro for hefty $5.1 bln

* GSK shares see biggest daily fall in 10 years (Adds latest shares, termination fee, more on drug competition)

Unilever swallows GSK's Indian Horlicks business for $3.8 billion

LONDON Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group's position in India by adding the popular malted drink.

UPDATE 4-Unilever swallows GSK's Indian Horlicks business for $3.8 bln

* To pay 3.3 billion euros in cash and shares in India unit (Adds segment performance, background)

GSK to buy cancer drugmaker Tesaro for $5.1 billion

LONDON, Dec 3 GlaxoSmithKline said on Monday it had agreed to buy U.S. cancer drug specialist Tesaro for $5.1 billion, marking a major biotech investment by the British drugmaker as its seeks to rebuild its pharmaceuticals portfolio.

India shares up for 6th day, Hindustan Unilever gets Horlicks boost

Dec 3 Indian stocks rose on Monday after a truce in trade relations between the United States and China, while shares in Hindustan Unilever jumped after its deal involving GlaxoSmithKline's Horlicks nutrition business.

RPT-Unilever to swallow GSK's Indian Horlicks business

Dec 3 Unilever Plc said on Monday it had agreed to buy GlaxoSmithKline's health food and drinks portfolio in India, Bangladesh and 20 other predominantly Asian markets.

Unilever to swallow GSK's Indian Horlicks business

Dec 3 Unilever Plc said on Monday it had agreed to buy GlaxoSmithKline's health food and drinks portfolio in India, Bangladesh and 20 other predominantly Asian markets.

Deals of the day-Mergers and acquisitions

Nov 29 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:

Select another date: